Promino Advances Rejuvenate Platform as Muscle Health Emerges as High-Growth Functional Beverage Category

Executive Summary

• Promino Nutritional Sciences announced a CAD $1.2 million financing to fund production expansion, distribution growth, and ongoing commercialization of its Rejuvenate Muscle Health™ platform.
• The company highlighted significant commercial momentum, now available in approximately 10,000 retail doors across North America and expanding e‑commerce, pharmacy, grocery, and direct‑to‑consumer channels.
• Promino outlined a disciplined three‑vertical growth strategy (Daily, NSF Certified for Sport®, Clinical) and ongoing product innovation into ready‑to‑drink formats and new flavors.

Key Details

• Financing: CAD $1.2 million private placement to support production scale‑up and distribution expansion.
• Distribution Reach: ~10,000 retail locations in North America; continued growth on Amazon/e‑commerce, pharmacy, grocery, and direct‑to‑consumer/social commerce platforms.
• Production Run: Executing its largest manufacturing run to date to meet near‑term sales demand.
• Platform Strategy: Scaling Rejuvenate across three verticals – Rejuvenate Daily, Promino – NSF Certified for Sport®, and Rejuvenate Clinical.
• Product Innovation: Development of ready‑to‑drink (RTD) formats, new powder and functional variants, expanded flavor portfolio, and targeted solutions for consumer, sport, and clinical markets.
• Market Context: Functional beverage sector growth driven by healthy aging, GLP‑1 weight‑loss therapies, and performance nutrition trends; major players like Coca‑Cola and PepsiCo increasing investment in similar categories.
• Leadership Quote: “We are building a scalable muscle health platform designed to meet a rapidly growing consumer need,” – Vito Sanzone, CEO.

Notable Quotes

“Muscle health is emerging as an important functional category, and our focus is on disciplined execution to strengthen our position within it.” – Vito Sanzone, Chief Executive Officer

Materiality Assessment: Non‑Material – Positive (the financing and operational updates are positive but not likely material to overall valuation).